Turmeric has been used medicinally for thousands of years, and curcumin, its main active compound, has been tested in human trials for dozens of diseases. The catch has always been getting enough of it absorbed to know whether it does anything.
Turmeric and its active curcuminoids are very poorly absorbed and rapidly broken down into inactive forms. Most of what is swallowed never reaches the bloodstream in a usable state.
That matters for research. Two trials can give the same dose of "curcumin" and deliver very different amounts to the blood. Researchers have responded with enhanced formulations (lipid particles, nanoparticles, micelles and phospholipid complexes) designed to get more of it absorbed.
Curcumin is almost insoluble in water, so much of it passes straight through the gut.
The gut wall and liver attach chemical tags (glucuronide and sulfate) that switch most of it into inactive forms.
What does get absorbed is removed from the blood quickly, leaving little time to reach tissues.
Studies of enhanced formulations report blood levels anywhere from a few times to more than a hundred times higher than standard curcumin, depending on the formulation and how it's measured.
Solid lipid particle formulations wrap curcumin in a protective fat layer, changing its route through the body. Watch it travel.
Curcumin sealed inside a solid lipid particle, protected and ready.
The lipid shield carries curcumin through harsh stomach acid.
Fats are absorbed via the lymph, which lets the particle avoid much of the liver's first-pass breakdown.
More active curcumin in the blood, for longer, carried to tissues throughout the body.
Curcumin is one of three main curcuminoids found naturally in turmeric. The other two, demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC), are less bioactive.
After an ordinary dose, most of the curcumin found in blood has already been tagged and inactivated. Studies that measure free (unconjugated) curcumin give a truer picture of how much active compound actually reaches tissues such as the joints, gut, liver and brain.
Whether curcumin reaches the brain in meaningful amounts is a central question for research in dementia, depression and multiple sclerosis, and the answer depends heavily on formulation.
Plain turmeric, standard extract or an enhanced form? Results rarely transfer from one to another.
A two-week trial and a one-year trial answer very different questions.
Small trials are a starting point. Look for larger studies in people who have the condition.
Without a control group it's hard to separate a real effect from expectation and chance.
A shift in a blood marker isn't the same as feeling better or living longer.
Cell and animal studies generate ideas; only human trials show what happens in people.
Browse the human research on curcumin, condition by condition.